Women and Coronary Artery Disease:

Similar documents
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

63 yo woman with chest pain

Microvascular Disease: How to Diagnose and What s its Treatment

FFR-CT Not Ready for Primetime

FFR Incorporating & Expanding it s use in Clinical Practice

How to Evaluate Microvascular Function and Angina. Myeong-Ho Yoon Ajou University Hospital

Maria Angela S. Cruz-Anacleto, MD

Diffuse Disease and Serial Stenoses. Bernard De Bruyne Cardiovascular Center Aalst Belgium

Control of Myocardial Blood Flow

CASE from South Korea

PET myocard perfusion & viability Riemer Slart

FRACTIONAL FLOW RESERVE Step-by-step measurement, Practical tips & Pitfalls

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Myocardial Perfusion: Positron Emission Tomography

Focus on Acute Coronary Syndromes

SPECT or PET for Cardiovascular Screening in High-Risk Patients

Diffuse Disease and Serial Stenoses

Debate Should we use FFR? I will say NO.

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Women and Heart Disease

Pathophysiology of Coronary Microvascular Dysfunction

Intervention: How and to which extent is technology helping us?

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

Better CABGs vs Better PCI Devices

Fractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου

CT or PET/CT for coronary artery disease

FFR in Multivessel Disease

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

Ischemia and Myocardial Infarction with Non-obstructive CAD

The Future of Coronary Physiology

Value of Index of Microvascular Resistance (IMR) in Microvascular Integrity

FFR? FFR-CT? Ischaemia testing?

Davos Mechanisms of ACS: the clinical perspective. Filippo Crea Institute of Cardiology Catholic University of the Sacred Heart Rome, Italy

A Normal Reference Coronary Flow Reserve is Associated With a Lower Mortality in Patients With Stable Coronary Artery Disease

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

Fractional Flow Reserve. A physiological approach to guide complex interventions

Women s Ischemia and cardiac rehabilitation

Kavitha Yaddanapudi Stony brook University New York

Physiology (FFR & IFR) is Essential in Daily Pratice. Martine Gilard Brest University - France

Coronary artery disease (CAD): Fractional Flow Reserve (FFR) for Pilots Risk Assessment. B. Haaff, R. Quast

Coronary Physiology and FFR. David H. Sibley MD FACC, FSCAI, FACP

Dr Sandra Birchem Cardiologist Cardiovascular Division Mayo Clinic Rochester and Mayo Clinic Health System MFMER slide-1

Detection Of Functional Significance of Coronary Stenoses Using Dynamic. Values Of Myocardial Blood Flow And Coronary Flow Reserve

Cardiopa(a ischemica a coronarie indenni : terapia medica o2male

CLINICAL CONSEQUENCES OF THE

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford

Management of stable CAD FFR guided therapy: the new gold standard

Complex CAD (5) PVD-P Valv. CM. Sub-Clinical Arterial (2) DBD/Frailty (2) Health Political (1) Personal (3)

Evaluating Clinical Risk and Guiding management with SPECT Imaging

Can We Safely Defer PCI. Yes, already proven

New Insight about FFR and IVUS MLA

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

PET: quantification of perfusion and beyond

Benefit of Performing PCI Based on FFR

Calculation of the Index of Microcirculatory Resistance without Coronary Wedge Pressure Measurement in the Presence of Epicardial Stenosis

Potential recommendations for CT coronary angiography in athletes

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Comparison between Myocardial Ischemia Evaluation by Fractional Flow Reserve and Myocardial Perfusion Scintigraphy

Diagnostic Challenges

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

Clinical case in perspective. Cases from Poland

Myocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas

Coronary interventions

Diabetes and Occult Coronary Artery Disease

Coronary Plaque Sealing: The DEFER Study and more...

Women and Ischemic Heart Disease Lessons Learned

Approach to Multi Vessel disease with STEMI

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria

Current and Future Imaging Trends in Risk Stratification for CAD

Stable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology

Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress test results

Technical Aspects and Clinical Indications of FFR

CorMicA A Randomized Trial of Coronary Function Testing in Angina and Non Obstructive Coronary Disease

Dave Kettles, St Dominics Hospital East London.

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

Diagnostic Algorithms

Who Cares About the Past?

Relations of Interest

MD F A F C A C MAS A N S C

CARDIOLOGY GRAND ROUNDS

Ischemic heart disease

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement

Validation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner

Malaysian Healthy Ageing Society

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

Invited Experts' Case Presentation and 5-Slides Focus Review

Diagnostic and Prognostic Value of Coronary Ca Score

Cho et al., 2009 Journal of Cardiology (2009), 54:

Heart Disease in Women: Diagnostic Approaches and Management

Ischemic Heart Disease in Women

Chest Pain in Women ;What is Your Diagnostic Plan? No Need for Noninvasive Test

Imaging Atheroma The quest for the Vulnerable Plaque

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Transcription:

Women and Coronary Artery Disease: Less is More? Interventional Cardiology 2017 32 th Annual International Symposium Snow Mass March 5-10 Yolande Appelman MD, PhD,FESC EAPCI-Women Interventional Cardiologist VU University Medical Center Amsterdam

Cardiovascular disease 1 in every 3 women dies of CVD or stroke 44 million women are affected by CVD in USA 80% can be prevented by lifestyle changes Cultural differences are often not accounted for Differences between men and women Non obstructive CAD and MVD SCAD TakoTsubo HFpEF

Gender differences CAD Loss of sex hormones (oestrogen) Women at presentation 10 yrs older More riskfactors (HT, dyslipidemia, diabetics) and higher impact Female specific riskfactors Blood vessels smaller (macro and micro)/stiffer more inflamed/more diffuse microvascular dysfunction endothelial and smooth muscle cell dysfunction more plaque erosion (instead of plaque rupture) less severe disease (gender paradox)!! Pepsine et al; JACC 2006;47 Suppl:S1-3 Shaw et al; JACC 2009;54:1561-75

Gender paradox Less obstruction but higher mortality Anderson R. et al. Circulation 2007;115:823-826

Non-obstructive CAD Less is more in women? In 20-30% in patients undergoing CAG Higher prevalence (50-70%) in women In 60% due to abnormal epicardial and/or MVD In 60-80% atherosclerosis is found with IVUS/OCT Increased mortality rate 1.5x Increased rehospitalization rate 40% Unneccesary repeat angiography 30% Worse quality of life Higher healthcare costs = obstructive CAD

By Denise Grady, April 18, 2006, The New York Times

Pathofysiology non-obstructive CAD Shaw L et al; Women and ischemic heart disease: evolving knowledge JACC 2009;54:1561-75

Myocardial ischemia Crea,Camici et al. EHJ.2014

Microvascular Camici and Crea, NEJM 2007

Angina in non-obstructive CAD Crea,Camici et al. EHJ.2014

Pathofysiology non-obstructive CAD Organic non-atherosclerotic causes Coronary aneurysm Myocardial bridging Coronary anomalies Functional disorder = spasm = Prinzmetal angina Microcirculatory abnormalities = microvascular Endothelial dysfunction (NO reduced) Impairment of endothelium-independent vasodilation True syndrome X

Pathofysiology non-obstructive CAD How to diagnose angina related to non-obstructive coronary artery disease? Depends on what you are looking for!

Spasm diagnosis Intracoronary acetylcholine Positive for epicardial coronary spasm if >75% focal or diffuse coronary diameter reduction Reproduction of angina and/or ischemic ECG changes Positive for microvascular spasm if Abcense of epicardial spasm Reproduction of angina and/or ischemic ECG changes Radico F JACC Cardiol Intv2014;7:453-63

Spasm diagnosis

MVD diagnosis Adenosine PET perfusion imaging Microvascular endothelium-independent dysfunction if CFR < 2.5 in absence of significant epicardial stenosis Golden standard for absolute myocardial blood flow Danad I, Appelman Y, Knaapen P Eur J Nucl Med Mol Imaging 2012

Diagnostic invasive assessment FFR = Fractional Flow Reserve CFR = Coronary Flow Reserve IMR = Index Microcirculatory Resistance

baseline CFR = hyperemia baseline hyperemia flow velocity

Imaging MVD and mechanism for male-female differences in CAD Patel M, Gould K JACC Cardiovasc Imaging 2016

Taqueti et al 2017 Circulation

Taqueti et al 2017 Circulation

Taqueti et al 2017 Circulation

Taqueti et al 2017 Circulation

Taqueti et al 2017 Circulation

Women lower burden of CAD Women higher rate CV events Women excess CV events independently associated with severely impaired CFR Women have hidden biological risk of ischemic heart disease Women need new treatment strategies

Treatment ESC guidelines MVD LIFESTYLE MODIFICATION! No study has evaluated the impact on MACE ESC guidelines on management of stable CAD Eur Heart J 2013

Conclusions Women with angina indeed less = more Higher prevalence non-obstructive CAD 60% is caused by MVD CV riskfactors play an important role Lower CFR higher CV risk CFR hidden biological risk of ischemic disease Lack of evidence on treatment strategies Exact mechanisms remain elusive more research is needed